Chlorpheniramine Maleate + Phenylpropanolamine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes carbinoxamine maleate + phenylpropanolamine HCl. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes cetirizina. It belongs to antihistaminic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes chlorpheniramine maleate. It belongs to antihistaminic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes chlorpheniramine maleate + D-pseudoephedrine SO4. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes chlorpheniramine maleate + D-pseudoephedrine SO4 + paracetamol. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes chlorpheniramine maleate + phenylephrine HCl. It is a pharmaceutical association. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes clonidine. It belongs to antihypertensive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes codeine phosfate + phenylephrine HCl + chlorpheniramine maleate. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes codeine phosphate. It belongs to analgesic narcotic / antiussive category. Bulk physical form: pellets, resinates. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes D-norpseudoephedrine HCI. It belongs to anorexic category. Bulk physical form: pellets, resinates. Final dosage form: caps/ tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes D-pseudoephedrine + cetirizina. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes D-pseudoephedrine HCI. It belongs to decongestant category. Bulk physical form: pellets, resinates. Final dosage form: caps/ tabs. Contact us for more information.